Ikarian Capital »

Mestera shares owned by Ikarian Capital

Quarter-by-quarter ownership of Mestera (MTSR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Mestera

Tip: Access up to 7 years of quarterly data

All positions including Mestera held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mestera by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.0M 172k 52.33
2025-06-30 $2.2M 77k 28.45
2025-03-31 $4.1M 150k 27.22

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Mestera

FMR
Vanguard Group
Henderson Group
BlackRock
Alphabet
VR Adviser
Wellington Management Company
Softbank Group Corp
State Street Corporation
Falcon Edge Capital
T. Rowe Price Investment Management
Geode Capital Management
RA Capital Management
Susquehanna International
Charles Schwab Investment Management

View all funds holding Mestera